Compare FURY & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FURY | HYPR |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical Specialities |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.8M | 101.3M |
| IPO Year | 2011 | 2021 |
| Metric | FURY | HYPR |
|---|---|---|
| Price | $0.57 | $0.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $1.70 | $1.59 |
| AVG Volume (30 Days) | 307.7K | ★ 380.3K |
| Earning Date | 08-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.21 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $13,563,000.00 |
| Revenue This Year | N/A | $50.75 |
| Revenue Next Year | N/A | $29.71 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.22 |
| 52 Week Low | $0.50 | $0.78 |
| 52 Week High | $1.02 | $2.22 |
| Indicator | FURY | HYPR |
|---|---|---|
| Relative Strength Index (RSI) | 40.03 | 30.64 |
| Support Level | $0.51 | N/A |
| Resistance Level | $0.57 | $1.39 |
| Average True Range (ATR) | 0.03 | 0.03 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 6.00 | 4.46 |
Fury Gold Mines Ltd is a Canadian-focused high-grade gold exploration company. The company's projects are strategically positioned in two prolific mining regions: the Eeyou Istchee James Bay Region of Quebec and the Kitikmeot Region in Nunavut. Fury Gold's project portfolio comprises the Committee Bay gold project in Nunavut, and the Eau Claire gold, Sakami gold, Elmer East gold and lithium, and Eleonore South gold projects in Quebec. Additionally, it also owns interests in the Kipawa rare earths project and has full ownership of the Zeus heavy rare earths project, both located in the Temiscamingue region of Quebec. The company operates in two reportable segments: Quebec and Nunavut.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.